Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of QLTLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list Atrix Laboratories, Inc. with 5 510(k) clearances. The most recent is a 510(k) clearance dated Sep 13, 2000: ATRISORB-D FREEFLOW BIOABSORBABLE GUIDED TISSUE REGENERATION (GTR) BARRIER WITH 4% DOXYC….
| Sep 13, 2000 | ATRISORB-D FREEFLOW BIOABSORBABLE GUIDED TISSUE REGENERATION (GTR) BARRIER WITH 4% DOXYCYCLINEK994137 · LYC | 510(k) clearances |
| Sep 8, 1998 | ATRISORB BIOABSORBABLE GUIDED TISSUE REGENERATION (GTR) BARRIER KITK982865 · NPK | 510(k) clearances |
| Mar 21, 1996 | ATRISORB BIOABSORBABLE GUIDED TISSUE REGNERATION(GTR)K955838 · NPK | 510(k) clearances |
| Feb 26, 1986 | CARDISUNY 501 AK852829 · DPS | 510(k) clearances |
| Jan 18, 1985 | MODEL 503FBK842759 · LOS | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
